Humab is looking for partners seeking to develop new antibody drugson the SynThese™ platform which allows for finding the most optimized antibodyin the shortest period of time.
HuMab | CEO : Changkyu Oh | 1212, 25, Yeonmujang 5ga-gil, Seongdong-gu, Seoul, Korea (04782)
TEL : +82) 2-2641-0150 | E-mail :
Copyright © 휴맵. All Rights Reserved.